Bering Capital
North America, California, United States, San Francisco
Description
Venture capital firm investing in biopharmaceuticals and medical devices.
Investor Profile
Bering Capital has made 4 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series C (50%)
- Post Ipo Equity (25%)
- Series D (25%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Information Technology
- Life Science
- Biopharma
- Biotechnology
- Oncology
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
